Cardinal Health, Inc. (NYSE:CAH) is scheduled to be releasing its earnings data before the market opens on Monday, November 6th. Analysts expect Cardinal Health to post earnings of $1.12 per share for the quarter. Cardinal Health has set its FY17 guidance at $4.85-5.10 EPS and its FY18 guidance at $5.60 EPS.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Wednesday, August 2nd. The company reported $1.31 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.24 by $0.07. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The business had revenue of $32.97 billion during the quarter, compared to analyst estimates of $32.73 billion. During the same quarter last year, the business earned $1.14 earnings per share. Cardinal Health’s quarterly revenue was up 5.0% compared to the same quarter last year. On average, analysts expect Cardinal Health to post $4.95 EPS for the current fiscal year and $5.53 EPS for the next fiscal year.

Cardinal Health, Inc. (CAH) opened at 66.71 on Monday. The firm’s 50-day moving average is $67.07 and its 200 day moving average is $72.28. Cardinal Health, Inc. has a 52-week low of $62.70 and a 52-week high of $84.88. The company has a market cap of $21.11 billion, a price-to-earnings ratio of 16.55 and a beta of 0.86.

The company also recently disclosed a quarterly dividend, which was paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd were issued a $0.4624 dividend. The ex-dividend date was Friday, September 29th. This represents a $1.85 annualized dividend and a dividend yield of 2.77%. Cardinal Health’s dividend payout ratio (DPR) is 45.79%.

Several analysts have recently weighed in on CAH shares. BidaskClub lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 11th. Cowen and Company upgraded Cardinal Health to a “buy” rating and set a $74.00 price objective for the company in a report on Tuesday, October 10th. Jefferies Group LLC restated a “hold” rating and issued a $77.00 price objective on shares of Cardinal Health in a report on Thursday, July 27th. Needham & Company LLC restated a “hold” rating on shares of Cardinal Health in a report on Sunday, September 10th. Finally, Robert W. Baird restated a “hold” rating and issued a $73.00 price objective on shares of Cardinal Health in a report on Sunday, September 17th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $76.54.

COPYRIGHT VIOLATION WARNING: “Cardinal Health, Inc. (CAH) to Release Earnings on Monday, November 6th” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another site, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this story can be accessed at

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Earnings History for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with's FREE daily email newsletter.